1 Change of general cognitive function measured by MMSE |
1 |
232 |
Mean Difference (IV, Fixed, 95% CI) |
1.48 [0.06, 2.91] |
2 Change of general cognitive function measured by ADAS‐cog+ score |
1 |
232 |
Mean Difference (IV, Fixed, 95% CI) |
‐6.11 [‐8.16, ‐4.06] |
3 Improvement of general cognitive function reported as responder rates |
1 |
232 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.57 [1.29, 1.91] |
4 Change of executive function measured by the Trail‐Making Test |
1 |
232 |
Mean Difference (IV, Fixed, 95% CI) |
‐15.31 [‐30.19, ‐0.43] |
5 Improvement of global function reported as responder rates |
1 |
232 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.07 [1.86, 5.07] |
6 Non‐serious adverse events |
1 |
232 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.54 [0.62, 3.84] |